KronoLife and Partners Launch the THÉVASE Longevity Brand and Develop a Certification Mark

MOU signing as Kronolife launches the THÉVASE brand
KronoLife,  a deep-tech startup from NANOTEC, NSTDA, has joined partners Evaya and VISBIO to advance longevity innovation, launching the co-brand “THÉVASE”, backing every product with research-verified performance, and jointly creating Thailand’s first Certification Mark for longevity products.

KronoLife Co., Ltd., a deep-tech startup under the National Nanotechnology Center (NANOTEC), National Science and Technology Development Agency (NSTDA), held a press conference and signing ceremony with Evaya International Co., Ltd. and VISBIO Co., Ltd. under the concept “From DeepTech to Longevity Innovation” to mark the successful transfer of technology from the public sector, by NANOTEC researchers, to KronoLife, a startup that builds on Thai herbal knowledge to develop active ingredients and product innovations for healthy ageing and longevity. The event also launched research-based products commercialised under the co-brand THÉVASE

The event took place at the 9th Thailand International Nanotechnology Conference (NanoThailand 2025), with Dr. Uracha Ruktanonchai, Executive Director of the National Nanotechnology Center (NANOTEC),  presiding over the opening ceremony.

Executive speaking on stage at the THÉVASE brand launch

Dr. Uracha said: “This partnership announcement and launch of KronoLife’s longevity innovations is another important milestone in transferring technology from NANOTEC, NSTDA, to the private sector. For more than 20 years, NANOTEC has served as a national hub for developing scientific and technological knowledge, particularly in deep technology (DeepTech) with the potential to create lasting economic and social impact, through mechanisms such as technology licensing, contract research and the creation of DeepTech startups, an important tool for moving research from the laboratory to the market, driven by the researchers themselves.”

“KronoLife is NANOTEC’s first startup focused on developing technologies and products in Longevity Innovation, and a clear example of building on NANOTEC research in the extraction and development of active ingredients from Thai herbs, together with anti-ageing and longevity testing, to create innovations for healthy ageing and longevity. This is in line with the emerging global Longevity Economy. This partnership is more than a signed document; it is the start of a new ecosystem connecting deep scientific knowledge with business value creation, to move Thailand towards the economy of the future.”

Executives holding the signed agreement at the THÉVASE launch

At the event, KronoLife Co., Ltd., represented by Dr. Tawin Iempridee, CEO, CTO and Co-founder, signed an agreement with Mr. Krittayot Chaowanapreecha, Managing Director of Evaya International Co., Ltd., and Mr. Kanamon Teeranantakul, Managing Director of Evaya International Co., Ltd., on the commercialisation of the product ReverZase Regenerate Cream  under the co-brand THÉVASE which will be marketed in Thailand and abroad. KronoLife Co., Ltd. also signed an agreement with VISBIO Co., Ltd., represented by Dr. Wuttipong Panitsettakorn, Managing Director and Co-founder of VISBIO Co., Ltd., to jointly develop a Certification Mark for longevity products, verifying the performance and credibility of innovations to international standards.

Executives and partners on stage at the ReverZase innovation press event

The event also featured a special panel discussion on “Innovating Longevity: Breaking Barriers, Defining Global Standards for the Future Economy” covering the development of deep technology (DeepTech), commercial scale-up and the creation of global standards to drive the longevity industry of the future.

Dr. Tawin Iempridee, CEO, CTO and Co-founder of KronoLife Co., Ltd., said: “I trained in cancer biology and have always focused on health-related research. I later extended this work into ageing biology, which underlies and accelerates non-communicable diseases (NCDs), including cancer and skin ageing. Our research focuses on extracting and developing plant-derived active ingredients that address the root causes of ageing, particularly “zombie cells” (senescent cells), one of the 12 hallmarks of ageing.”

Panel discussion at the THÉVASE longevity brand launch

The active ingredient innovation  ReverZase which KronoLife is commercialising with Evaya International under the brand THÉVASE is one of the research team’s  “flagship” innovations. The ingredient ReverZase  from the Thai herb Thai Spider Lily, is selected and extracted from natural sources using deep technology. According to the team’s research, the resulting active ingredient shows strong potential in studies targeting cellular ageing processes, age-related inflammation, mitochondrial function and DNA damage, all key hallmarks of ageing. The innovationwon aBronze Medal at the 49th Geneva International Exhibition of Inventions 2024 in Switzerland, was runner-up in the Cosmeceutical and Herbal Innovation Award with Business Link 2024, and received an Innovation Excellence Award at Pathum Innotech 2025.

Dr. Tawin added: “As a researcher who also works to meet private-sector needs, I see the pain points companies face when marketing innovations they have licensed. Deep-tech research in particular is hard to communicate and needs a different marketing approach from ordinary products. KronoLife therefore chose to commercialise its innovations itself, believing that telling the research story as the technology owner, together with partners, from laboratory results to clinical results and from the active-ingredient particles to the finished product, will set the products apart and overcome the pain points innovation products have faced.”

Panelists on stage at the THÉVASE brand launch

Meanwhile, Mr. Krittayot Chaowanapreecha, Managing Director of Evaya International Co., Ltd., said: “Longevity is becoming a trend among health-conscious people, but many may not yet clearly understand what a true longevity product is. Our marketing approach for the brand THÉVASE will therefore initially focus on consumer education by Dr. Tawin about longevity and how our products perform. Distribution will be both online and offline, through our own stores and leading pharmacies, focusing on consumers aged 35 and over. We expect the products to be available by this December. The first product on sale will be  ReverZase Regenerate Cream followed by a sunscreen and a hair-care spray. We are targeting sales of more than 100,000 units by 2026.”

Executives at the product booth during the THÉVASE launch

“This partnership is an important starting point for building an ecosystem for developing longevity products. It is not just about launching products; they must be products of real quality, with safety in mind and proper testing. We see this as a good start. Other businesses with the same commitment are welcome to join us in further development in the future.”

In addition, Dr. Wuttipong Panitsettakorn, Managing Director and Co-founder of VISBIO Co., Ltd., said: “VISBIO is a testing laboratory providing analysis and testing for products such as plants, herbs, extracts, cosmetics, dietary supplements, pharmaceuticals and hair-care products, focusing on laboratory-based scientific testing to assess aspects such as active-compound content, efficacy, safety and antimicrobial activity. We have issued more than 1,000 test reports over the past three years.”

Kronolife partners launch the THÉVASE brand with a longevity innovation and a certification mark

“Longevity is now widely used to sell products, yet sampling of products on the market still finds active-compound content that does not match what is declared on the packaging. To bring clarity to the many kinds of longevity products and build consumer confidence, VISBIO, as an independent testing body, is working with KronoLife to establish a Certification Mark for longevity products, the first of its kind in Thailand, to verify the performance and credibility of innovations to international standards. The requirements for use of the mark are currently being developed in accordance with the regulations of the Department of Intellectual Property.” Dr. Wuttipong said in closing.